Variant report
Variant | nsv524030 |
---|---|
Chromosome Location | chr3:25450943-25453181 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6550974 | chr3:25450943-25450944 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs185092803 | chr3:25450945-25450946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs80329684 | chr3:25450946-25450947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536221941 | chr3:25450967-25450968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370972046 | chr3:25450972-25450973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116690281 | chr3:25450984-25450985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569718818 | chr3:25450990-25450991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538833320 | chr3:25450998-25450999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7630496 | chr3:25451000-25451001 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs7630502 | chr3:25451024-25451025 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs11716604 | chr3:25451031-25451032 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs554576678 | chr3:25451063-25451064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189944437 | chr3:25451064-25451065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543366788 | chr3:25451070-25451071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7620529 | chr3:25451077-25451078 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs193027220 | chr3:25451084-25451085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546426604 | chr3:25451116-25451117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559673165 | chr3:25451130-25451131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185181906 | chr3:25451186-25451187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548917227 | chr3:25451245-25451246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2364117 | chr3:25451254-25451255 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs189731735 | chr3:25451278-25451279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569283152 | chr3:25451280-25451281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549753757 | chr3:25451285-25451286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569769760 | chr3:25451305-25451306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538351675 | chr3:25451311-25451312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529472879 | chr3:25451338-25451339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548004784 | chr3:25451359-25451360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538979827 | chr3:25451379-25451380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558745070 | chr3:25451382-25451383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565720731 | chr3:25451435-25451436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534781221 | chr3:25451457-25451458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2364118 | chr3:25451461-25451462 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs376030601 | chr3:25451567-25451568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145626364 | chr3:25451569-25451570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138263137 | chr3:25451570-25451571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577298898 | chr3:25451604-25451605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116095089 | chr3:25451625-25451626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559765338 | chr3:25451658-25451659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181333910 | chr3:25451659-25451660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185018674 | chr3:25451671-25451672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572555226 | chr3:25451706-25451707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141417002 | chr3:25451707-25451708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143395692 | chr3:25451709-25451710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148343786 | chr3:25451809-25451810 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141530427 | chr3:25451810-25451811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114781160 | chr3:25451826-25451827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555144508 | chr3:25451841-25451842 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188269265 | chr3:25451861-25451862 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150887641 | chr3:25451863-25451864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Tracheal agenesis | 20877625 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Glioblastoma multiforme | 21510904 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:25449800-25451600 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr3:25450200-25451600 | Weak transcription | Stomach Mucosa | stomach |
3 | chr3:25451400-25454400 | Enhancers | Fetal Intestine Large | intestine |
4 | chr3:25451600-25451800 | Enhancers | Fetal Kidney | kidney |
5 | chr3:25451600-25453400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr3:25451600-25454200 | Enhancers | Stomach Mucosa | stomach |
7 | chr3:25451600-25454400 | Enhancers | Fetal Intestine Small | intestine |
8 | chr3:25451800-25453000 | Weak transcription | Fetal Kidney | kidney |
9 | chr3:25451800-25453600 | Enhancers | A549 | lung |
10 | chr3:25451800-25454000 | Enhancers | HepG2 | liver |
11 | chr3:25452200-25453400 | Enhancers | Placenta | Placenta |
12 | chr3:25452200-25453600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr3:25452200-25453600 | Enhancers | Duodenum Mucosa | Duodenum |
14 | chr3:25452600-25454200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
15 | chr3:25453000-25453200 | Enhancers | Fetal Kidney | kidney |
16 | chr3:25453000-25453400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr3:25453000-25453400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |